With your support, we have been able to fund outstanding research, leading toward cures and improved quality of life for children with cancer. Browse through more than 1,000 funded projects below.
Use the search tool to refine your results. You can also click on a heading to sort by project title, institution name, or year the grant was awarded. Click on the project title to read more information.
You can learn about ALSF's grant review process here.
ALSF Funded Research Projects
|Project Title||Institution / Principal Investigator(s)||Grant Type||Year||State|
|Tracking Ewing Sarcoma Origin by Developmental and Trans-species Genomics||St. Anna Children´s Cancer Research Institute / Heinrich Kovar, PhD||Crazy 8 Awards||2021|
|Small Molecule Degraders for Targeting Transcription Factor Drivers of Childhood Cancers||St. Jude Children's Research Hospital / Charles G. Mullighan, MBBS(Hons), MSc, MD, FRACP, FRCPA||Crazy 8 Awards||2021||Tennessee|
|Drugging MYCN||Children's Hospital of Philadelphia / Yael Mossé, MD||Crazy 8 Awards||2021||Pennsylvania|
|Barcoding Pediatric Leukemia for Therapeutic Purposes||Boston Children's Hospital / Leonard Zon, MD||Crazy 8 Awards||2021||Massachusetts|
|Practical, Reproducible, and Statistically-Rigorous Workflows for Single-Nucleus Analysis of Childhood Cancer Data||Johns Hopkins Bloomberg School of Public Health / Stephanie C. Hicks, PhD||Crazy 8 Pilots||2019||Maryland|
|Targeting the Surface-ome of Embryonal Brain Tumors||Institut Curie / Olivier Ayrault, PhD||Crazy 8 Pilots||2019|
|Targeting MYCN||Children's Hospital of Philadelphia / Yael Mossé, MD & Julie Park, MD||Crazy 8 Pilots||2019||Pennsylvania|
|Dissecting Microenvironmental Interactions in Pediatric High-Grade Gliomas that Promote Tumor Growth||Dana-Farber Cancer Institute / Mariella G. Filbin, MD/PhD||Crazy 8 Pilots||2019||Massachusetts|
|Platform development for target identification in high risk pediatric leukemias||Columbia University / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD||Crazy 8 Pilots||2019||New York|
|Platform development for target identification in high risk pediatric leukemias||St. Jude Children's Research Hospital / Adolfo A Ferrando, MD/PhD, Charles Mullighan, MD||Crazy 8 Pilots||2019||Tennessee|